The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

President Donald Trump warned drugmakers in a private meeting that tariffs are coming and said companies should hustle to ...

Medicare's new drug price negotiation program aims to save billions for the government and seniors. Starting in 2026, this initiative could significantly reduce out-of-pocket costs for millions of ...

Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...

Ozempic, Rybelsus and Wegovy. These three medications are Type 2 diabetes drugs that are also used to treat cardiovascular disease and obesity. Between October 2023 and October 2024, the cost of the ...

BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But ...

Gold prices in India retreated from record highs, falling by Rs 700 per 10 grams due to weak demand and global trends. Silver ...

With 2025 underway, the AFS Health Care team highlights some of the most pressing legal issues facing the health care industry this year.

Tariffs are one of the most talked-about policies of President Donald Trump’s new proposals, but a new report indicates that ...